|
Monday, February 28 — 8:00 AM — CC 101 A/B
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section F - Bone & Soft Tissue Pathology
Chaired by: Elizabeth Montgomery and G. Petur Nielsen
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Fusion of Non-Muscle Myosin MYH9 to the USP6Oncogene in Nodular Fasciitis.
(39)
MR Erickson-Johnson, MM Chou, BR Evers, CW Roth, AR Seys, L Jin, X Wang, Y Ye, AW Lau, AM Oliveira - Univeristy of Pennsylvania School of Medicine, Philadelphia; Mayo Clinic, Rochester, MN
|  Add |
| 8:15 |
MUC4 Is a Highly Sensitive and Specific Marker for Low-Grade Fibromyxoid Sarcoma.
(36)
LA Doyle, E Moller, F Mertens, JL Hornick - Brigham and Women's Hospital, Boston, MA; Lund University Hospital, Lund, Sweden
| Add |
| 8:30 |
Ossifying Fibromyxoid Tumor of Soft Parts (OFMT): A Clinicopathologic, Proteomic and Genomic Study.
(45)
RP Graham, SM Dry, X Li, SW Binder, A Dogan, AL Folpe - Mayo Clinic, Rochester, MN; UCLA, Los Angeles, CA
| Add |
| 8:45 |
Epithelioid Rhabdomyosarcoma: A Morphologically Distinct Variant.
(50)
VY Jo, CDM Fletcher - Brigham and Women's Hospital, Boston, MA
| Add |
| 9:00 |
Primary Myoepithelioma of Bone.
(57)
PJ Kurzawa, PG Nielsen, S Kattapuram, FJ Hornicek, AE Rosenberg - Great Poland Cancer Centre, Poznan, Wielkopolska, Poland; Massachusetts General Hospital, Boston
| Add |
| 9:15 |
Malignant Fibrous Histiocytoma and Fibrosarcoma of Bone in 2011: What's New?
(72)
S Romeo, JVMG Bovee, I Carraretto, R Tirabosco, C Natali, HM Kroon, L Zanatta, R Sciot, F Mertens, N Athanasou, M Alberghini, PCW Hogendoorn, AP Dei Tos - Treviso Regional Hospital, Treviso, Italy; Leiden University Medical Center, Netherlands; Royal National Orthopaedic Hospital, London, United Kingdom; Rovigo Regional Hospital, Rovigo, Italy; Leuven University, Netherlands; Lund University Hospital, Lund, Sweden; Nuffield Orthopaedic Center, Oxford, United Kingdom; Rizzoli Orthopaedic Institute, Bologna, Italy
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
| 11:00 |
Identification of a Novel, Recurrent HEY1-NCOA2 Fusion in Mesenchymal Chondrosarcoma Based on a Genome-Wide Screen of Exon-Level Expression Data.
(82)
L Wang, T Motoi, R Khanin, N Socci, A Olshen, F Mertens, J Bridge, P Dal Cin, EJ Rushing, J Fanburg-Smith, C Antonescu, M Hameed, M Ladanyi - Memorial Sloan-Kettering Cancer Center, New York, NY; Lund University Hospital, Lund, Sweden; University of Nebraska Medical Center, Omaha; Brigham & Women's Hospital, Boston, MA; AFIP, Washington, DC; Inova Fairfax Hospital, Falls Church, VA
| Add |
| 11:15 |
Consistent t(1;10) Abnormality in Both Myxoinflammatory Fibroblastic Sarcoma (MIFS) and Hemosiderotic Fibrolipomatous Tumor (HFLT).
(21)
CR Antonescu, L Zhang, GP Nielsen, AE Rosenberg, P Dal Cin, CD Fletcher - Memorial Sloan-Kettering Cancer Ctr, New York, NY; Massachusettes General Hospital, Boston; Brigham & Women's Hospital, Boston, MA
| Add |
| 11:30 |
Myxoid Liposarcoma: A Clinicopathologic Study of 27 Cases of Primary Untreated Disease with Particular Focus on So-Called Transitional and Round Cell Areas.
(42)
KJ Fritchie, D Wang, JR Goldblum, SA Lietman, J Bodo, SD Billings, BP Rubin - Cleveland Clinic, OH
| Add |
| 11:45 |
Claudin-5: A Novel, Highly Sensitive and Specific Endothelial Marker.
(73)
W Shon, LA Popp, AL Folpe - Mayo Clinic, Rochester, MN
| Add |
|
|
